Literature DB >> 1420622

Ischaemia of the preterm brain.

G Greisen1.   

Abstract

Much has been learned about the diagnosis and prognosis of periventricalar leucomalacia during the past 10 years. The understanding of its causation, however, has not advanced much. Still, the candidate for the principal role is focal ischaemia in the particularly vulnerable regions of the brain. It has been difficult to provide direct supportive evidence for this hypothesis. It has not been possible to define a threshold for (global) cerebral blood flow (CBF) under which brain damage or electrical dysfunction occurs. Three hypothetical explanations for the lack of clear relation between global CBF and electrical brain activity of the preterm infant must be examined more closely: (1) the very low levels of CBF are adequate, (2) global CBF does not reflect the perfusion of the white matter, or (3) acute white-matter ischaemia does not result in cerebro-electrical dysfunction. In view of the practical importance, more research is indicated.

Entities:  

Mesh:

Year:  1992        PMID: 1420622     DOI: 10.1159/000243877

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  4 in total

1.  Lipid peroxides are generated by the fetal rat brain after episodes of global ischemia in utero.

Authors:  S Glozman; E Yavin
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

Review 2.  Docosahexaenoic acid accumulation in the prenatal brain: prooxidant and antioxidant features.

Authors:  E Yavin; S Glozman; P Green
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

3.  Cerebral blood flow and oxygenation in ovine fetus: responses to superimposed hypoxia at both low and high altitude.

Authors:  Jorge Pereyra Pena; Takuji Tomimatsu; Douglas P Hatran; Lisa L McGill; Lawrence D Longo
Journal:  J Physiol       Date:  2006-10-26       Impact factor: 5.182

Review 4.  Magnetic resonance imaging of the neonatal brain.

Authors:  Ariel Prager; Sudipta Roychowdhury
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.